Does ENTECAVIR Cause Interstitial lung disease? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Interstitial lung disease have been filed in association with ENTECAVIR (Entecavir). This represents 0.6% of all adverse event reports for ENTECAVIR.
26
Reports of Interstitial lung disease with ENTECAVIR
0.6%
of all ENTECAVIR reports
4
Deaths
13
Hospitalizations
How Dangerous Is Interstitial lung disease From ENTECAVIR?
Of the 26 reports, 4 (15.4%) resulted in death, 13 (50.0%) required hospitalization, and 3 (11.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENTECAVIR. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does ENTECAVIR Cause?
Drug resistance (312)
Death (298)
Drug ineffective (207)
Hepatitis b (166)
Off label use (129)
Maternal exposure during pregnancy (126)
Viral mutation identified (121)
Renal impairment (118)
Pathogen resistance (115)
Fatigue (108)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ENTECAVIR Alternatives Have Lower Interstitial lung disease Risk?
ENTECAVIR vs ENTINOSTAT
ENTECAVIR vs ENTRECTINIB
ENTECAVIR vs ENZALUTAMIDE
ENTECAVIR vs EPCORITAMAB
ENTECAVIR vs EPCORITAMAB-BYSP